CARDIOTOXICITY RISK IN PATIENTS WITH NON‐HODGKIN LYMPHOMA RECEIVING EPOCH AFTER PRIOR ANTHRACYCLINE EXPOSURE
Buege, M. J., Dao, P. H., Drill, E., Horwitz, S. M., LeVoir, A., Pak, T., Peterson, T. J., Matasar, M. J.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
BENDAMUSTINE, RITUXIMAB, AND POLATUZUMAB VEDOTIN FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: SINGLE‐CENTER REAL‐WORLD EXPERIENCE
Farina, K. A, Drill, E, Buie, L. W, Falchi, L, Kumar, A, Noy, A, Palomba, M L, Salles, G, Straus, D. J, Zelenetz, A. D, Buege, M. J, Batlevi, C. L
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
TIME TO SECOND LINE BRUTON TYROSINE KINASE THERAPY AND AGE AT ITS INITIATION ARE STRONGLY ASSOCIATED WITH SUBSEQUENT OVERALL SURVIVAL IN PATIENTS WITH FIRST RELAPSE OF MANTLE CELL LYMPHOMA
Villa, D., Jiang, A., Crosbie, N., Rule, S., McCulloch, R., Visco, C., Buege, M. J., Kumar, A., Bond, D., Paludo, J., Maurer, M. J., Thanarajasingam, G., Baech, J., El‐Galaly, T., Kugathasan, L., Gerrie, A. S., Lewis, D.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article